Insmed Research Development from 2010 to 2026
| INSM Stock | USD 157.16 3.18 2.07% |
Research Development | First Reported 1999-03-31 | Previous Quarter 177.2 M | Current Value 186.4 M | Quarterly Volatility 48.1 M |
Check Insmed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Insmed's main balance sheet or income statement drivers, such as Depreciation And Amortization of 13.3 M, Interest Expense of 102.5 M or Total Revenue of 439.2 M, as well as many indicators such as Price To Sales Ratio of 34.02, Dividend Yield of 0.0 or PTB Ratio of 37.5. Insmed financial statements analysis is a perfect complement when working with Insmed Valuation or Volatility modules.
Insmed | Research Development | Build AI portfolio with Insmed Stock |
Evaluating Insmed's Research Development across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Insmed Inc's fundamental strength.
Latest Insmed's Research Development Growth Pattern
Below is the plot of the Research Development of Insmed Inc over the last few years. It is Insmed's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Insmed's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Insmed Research Development Regression Statistics
| Arithmetic Mean | 245,871,777 | |
| Geometric Mean | 129,090,367 | |
| Coefficient Of Variation | 101.43 | |
| Mean Deviation | 208,830,534 | |
| Median | 131,711,000 | |
| Standard Deviation | 249,390,295 | |
| Sample Variance | 62195.5T | |
| Range | 716.9M | |
| R-Value | 0.92 | |
| Mean Square Error | 10444.2T | |
| R-Squared | 0.84 | |
| Slope | 45,332,788 | |
| Total Sum of Squares | 995128.3T |
Insmed Research Development History
About Insmed Financial Statements
Insmed investors utilize fundamental indicators, such as Research Development, to predict how Insmed Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Research Development | 688.1 M | 722.5 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Insmed Correlation against competitors. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Will Biotechnology sector continue expanding? Could Insmed diversify its offerings? Factors like these will boost the valuation of Insmed. Market participants price Insmed higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Insmed data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (6.18) | Revenue Per Share | Quarterly Revenue Growth 0.524 | Return On Assets | Return On Equity |
Investors evaluate Insmed Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Insmed's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Insmed's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Insmed's market price signifies the transaction level at which participants voluntarily complete trades.